These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 14045902)

  • 1. TURNOVER OF PROTHROMBIN AND FACTORS VII, IX AND X IN STATES OF HYPOCOAGULABILITY.
    HELLEMANS J; DEVREKER R; VORLAT M; VERSTRAETE M
    Acta Haematol; 1963 Jul; 30():35-41. PubMed ID: 14045902
    [No Abstract]   [Full Text] [Related]  

  • 2. SURVIVAL TIME OF PROTHROMBIN AND FACTORS VII, IX AND X AFTER COMPLETELY SYNTHESIS BLOCKING DOSES OF COUMARIN DERIVATIVES.
    HELLEMANS J; VORLAT M; VERSTRAETE M
    Br J Haematol; 1963 Oct; 9():506-12. PubMed ID: 14076133
    [No Abstract]   [Full Text] [Related]  

  • 3. LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.
    SHAW S; PEGRUM GD; WOLFF S
    J Clin Pathol; 1965 May; 18(3):327-9. PubMed ID: 14304246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANTICOAGULANT ACTIVITY OF ACENOCOUMARIN IN EXPERIMENTAL ANIMALS.
    JINDAL MN; SHAH DS
    Indian J Physiol Pharmacol; 1964 Jan; 8():72-9. PubMed ID: 14248536
    [No Abstract]   [Full Text] [Related]  

  • 5. [THROMBOTEST IN ANTICOAGULANT CONTROL: A COMPARATIVE STUDY WITH QUICK'S ONE-STAGE PROTHROMBIN DETERMINATION].
    RETIEF FP
    S Afr Med J; 1964 Jul; 38():534-8. PubMed ID: 14176704
    [No Abstract]   [Full Text] [Related]  

  • 6. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY?
    SAMUELSSON SM; LILIENBERG G
    Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757
    [No Abstract]   [Full Text] [Related]  

  • 7. OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION.
    PAPAHADJOPOULOS D; HANAHAN DJ
    Biochim Biophys Acta; 1964 Aug; 90():436-9. PubMed ID: 14220741
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 10. EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II.
    KAZMIER F; SPITTELL JA; THOMPSON JJ; OWEN CA
    Arch Intern Med; 1965 Jun; 115():667-73. PubMed ID: 14299436
    [No Abstract]   [Full Text] [Related]  

  • 11. PROTHROMBIN LEVELS DURING THE FIRST YEAR OF LIFE. OBSERVATIONS FOLLOWED BY THE SYNTHETIC SUBSTRATE (TAME) ASSAY OF NORMAL FULL-TERM INFANTS.
    GLUECK HI; SUTHERLAND J; GLESER G
    Am J Dis Child; 1964 Jun; 107():612-7. PubMed ID: 14133821
    [No Abstract]   [Full Text] [Related]  

  • 12. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY.
    DOKU HC; TAYLOR RG; SISE HS; BECKER R
    J Dent Res; 1964; 43():323-30. PubMed ID: 14159035
    [No Abstract]   [Full Text] [Related]  

  • 13. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
    LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS
    Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274
    [No Abstract]   [Full Text] [Related]  

  • 14. [PRIMARY IDIOPATHIC HYPERACTIVITY OF PROTHROMBIN AND FACTOR VII].
    GAY A; ALZETTA A; MONTALE P
    Arch Maragliano Patol Clin; 1963 Dec; 19():785-91. PubMed ID: 14120627
    [No Abstract]   [Full Text] [Related]  

  • 15. HYPERCOAGULABILITY OF BLOOD AFTER BURN TRAUMA IN RATS. A PRELIMINARY REPORT.
    ARTURSON G; WALLENIUS G
    Acta Chir Scand; 1964 Oct; 128():340-5. PubMed ID: 14211288
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of neodymium 3-sulfo-isonicotinate on the mechanism of coagulation in guinea pigs and rabbits].
    Tremblay J; Archambault A
    Rev Can Biol; 1967 Mar; 26(1):1-9. PubMed ID: 6053477
    [No Abstract]   [Full Text] [Related]  

  • 17. OMEPHINE, A NEW ANTICOAGULANT.
    KOPTELOVA MN
    Fed Proc Transl Suppl; 1963; 22():1256-8. PubMed ID: 14079350
    [No Abstract]   [Full Text] [Related]  

  • 18. ANTICOAGULANT THERAPY--BOON OR BANE?
    CELANDER DR; CELANDER E; MARTIN CG
    J Am Osteopath Assoc; 1964 Dec; 64():359-65. PubMed ID: 14233113
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental warfarin poisoning in the dog. Platelet function, coagulation and fibrinolysis.
    Forbes CD; Thomson C; Prentice CR; McNicol GP; McEwan AD
    J Comp Pathol; 1973 Apr; 83(2):173-80. PubMed ID: 4761660
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.
    DIDISHEIM P; LOEB J; BLATRIX C; SOULIER JP
    J Lab Clin Med; 1959 Feb; 53(2):322-30. PubMed ID: 13621053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.